Change of Registered Office

Summary by AI BETAClose X

Fortis Frontier PLC, an AIM Rule 15 cash shell, has announced a change to its registered office following the disposal of its trading subsidiary, Concepta Diagnostics Limited. The company's registered office has moved from Cardiff to c/o BPE Solicitors LLP in Cheltenham. This administrative change occurs as the company considers strategic options to maximize shareholder value after becoming a cash shell on November 10, 2025.

Disclaimer*

Fortis Frontier PLC
14 May 2026
 

 

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

 

Change of Registered Office

 

Following the disposal of its trading subsidiary, Concepta Diagnostics Limited, Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell, announces that its registered office has moved from The Maltings, East Tyndall Street, Cardiff CF24 5EA to c/o BPE Solicitors LLP, St James House, St James Square, Cheltenham GL50 3PR.

 

For further information contact:

 

Fortis Frontier PLC

www.fortisfrontierplc-ir.com

Adam Reynolds, Executive Chairman

via Walbrook PR



SPARK Advisory Partners Limited (NOMAD)

Tel: +44 (0)20 3368 3550

Neil Baldwin / Dillon Wall




Singer Capital Markets (Broker)

Tel: +44 (0)20 7496 3000

James Serjeant / Russell Cook / Amber Higgs




Walbrook PR Ltd (Media & IR)

Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

 

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 cash shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings